CERCIT Workshop: Texas Cancer Registry; Medicaid; Registry Linked Claims Data

Similar documents
Spending estimates from Cancer Care Spending

DAYS IN PANCREATIC CANCER

CERCIT Project 2: Assessing the Quality of Cancer Treatment in Texas. Sharon Giordano

THE SURVIVORSHIP EXPERIENCE IN PANCREATIC CANCER

The Linked SEER-Medicare Data and Cancer Effectiveness Research

National Cancer Institute

Provider Level Analyses of Screening Mammography Use in Women with Limited Life Expectancy

The Use of Clinical Trial Data in Combination with External Data Sources to Examine Novel Cancer Research Questions: A Modified Big Data Approach

Toxicities of Chemotherapy Regimens used in Early Breast Cancer

UTILIZATION OF ONCOTYPE DX TO GUIDE TREATMENT FOR EARLY STAGE BREAST CANCER. Rosemary Cress, DrPH

Using claims data to investigate RT use at the end of life. B. Ashleigh Guadagnolo, MD, MPH Associate Professor M.D. Anderson Cancer Center

Epidemiology in Texas 2006 Annual Report. Cancer

Augmenting Smoking History in Cancer Registry Data through Health Administrative Claims Data

Tools, Reports, and Resources

Geographic Variation of Advanced Stage Colorectal Cancer in California

Utilization of OncoType DX Test for

Leveraging the California Cancer Registry to Measure & Improve the Quality of Cancer Care

Predictors of Palliative Therapy Receipt in Stage IV Colorectal Cancer

Surveillance of Pancreatic Cancer Patients Following Surgical Resection

Linkage of Indiana State Cancer Registry and Indiana Network for Patient Care

Gary M. Levin, BA, CTR FCDS Annual Conference 7/26/2017

Presentation for DHSS 14 September Senior Statistician

Annual Report to the Nation on the Status of Cancer, , Featuring Survival Questions and Answers

Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care Study

WHAT FACTORS INFLUENCE AN ANALYSIS OF HOSPITALIZATIONS AMONG DYING CANCER PATIENTS? AGGRESSIVE END-OF-LIFE CANCER CARE. Deesha Patel May 11, 2011

Utilization of BRCA Testing. Breast and Ovarian Cancer in Texas

Christie Eheman, PhD NAACCR 6/2012

Basic and Preventive Care

Provider Contribution to Overuse and Underuse of Colorectal Cancer Screening (mostly colonoscopy)

Estimating Medicaid Costs for Cardiovascular Disease: A Claims-based Approach

ORIGINAL INVESTIGATION. Effect of a Dementia Diagnosis on Survival of Older Patients After a Diagnosis of Breast, Colon, or Prostate Cancer

The Tennessee EHDI Information System

Reimbursement cuts and changes in urologist use of androgen deprivation therapy for prostate cancer

STUDY. The Association of Medicare Health Care Delivery Systems With Stage at Diagnosis and Survival for Patients With Melanoma

2018 Texas Cancer Registry Annual Report

DEPARTMENT OF HEALTH AND HUMAN SERVICES DIVISION OF PUBLIC HEALTH MANDY COHEN, MD, MPH SECRETARY

Predictors of Screening Mammography in Patients with Early vs. Advanced Stage Colorectal and Lung Cancer: A Population-Based Study

Ian Landry, MPH Beth Schmidt, MSPH

Hospital and Medical Care Days in Pancreatic Cancer

Trends and Comparative Effectiveness in Treatment of Stage IV Colorectal Adenocarcinoma

Incidence cost estimates or longitudinal estimates of medical

Factors Associated with Initial Treatment for Clinically Localized Prostate Cancer

Androgen deprivation therapy for treatment of localized prostate cancer and risk of

TITLE: Outcomes of Screening Mammography in Elderly Women

Examining Racial Differences in Utilization of Genetic Counseling Services in Hereditary Cancer Network Database

Hospital Compare Database Recommendations

The New CP 3 R Application And Revisions To Standard 4.6 Integration Of The NCDB With The Accreditation Process

THE COST DRIVERS OF CANCER CARE

Unplanned Hospitalizations and Readmissions among Elderly Patients with GI Cancer

Racial Variation In Quality Of Care Among Medicare+Choice Enrollees

Scarlett Gomez, MPH, PhD Cancer Prevention Institute of California NAACCR 2017 conference, Albuquerque NM June 2017

Survival among Native American Adolescent and Young Adult Cancer Patients in California

Monitoring the HCV care cascade to inform public health action

The Commission on Cancer: Reengineering the National Cancer Data Base

WHI Medicare Data. Joe Larson, Roberta Ray, Mary Pettinger September 9, 2016

Gastrointestinal Cancer

A New Measure to Assess the Completeness of Case Ascertainment

Welcome and Texas DSHS Overview

Early Age and Late Stage Diagnosis of Colorectal Cancer Among American Indian Residents of Montana,

The Cancer Burden in California. Janet Bates MD MPH California Cancer Registry California Department of Public Health April 25, 2012

Colorectal Cancer Screening in Washington State

Construction of a North American Cancer Survival Index to Measure Progress of Cancer Control Efforts

Methods and Limitations Overview

Commission on Cancer Updates

Meaningful Use Overview

Evaluation of Record Linkage for SEER breast cancer registries to Oncotype DX tests

Alarge body of evidence documents

Provider Continuity Prior to the Diagnosis of Advanced Lung Cancer and End-of-Life Care

Patient Navigation Research Program (PNRP) Evaluation Design and Implementation

Volker Arndt, MD, MPH National Institute for Cancer Epidemiology and Registration (NICER) Zurich

John T. Mather Memorial Hospital and St. Charles Hospital Community Health Needs Assessment: Cancer Executive Summary

BY-STATE MENTAL HEALTH SERVICES AND EXPENDITURES IN MEDICAID, 1999

Hospital Discharge Data

NIH Public Access Author Manuscript Ann Surg Oncol. Author manuscript; available in PMC 2012 August 01.

Whitney M. Randolph, Jonathan D. Mahnken, James S. Goodwin, and Jean L. Freeman

Translating Health Services Research in Sickle Cell Disease to Policy

Day-to-Day Activities The Fellow will have opportunities to:

Ethnic disparities in melanoma diagnosis and survival

Retention of Enrollees Following a Cancer Diagnosis Within Health Maintenance Organizations in the Cancer Research Network

Study Links Use of Intraoperative Neuromonitoring during Spine Surgery to Improved Outcomes, Lower Opioid Use

The Opioid Epidemic and Enhanced Opioid Surveillance in Missouri

Improving Cancer Surveillance and Mortality Data for AI/AN Populations

Boot Camp /5/15

Patterns of Care in Patients with Cervical Cancer:

Complete Central Registry Treatment Information Requires Ongoing Reporting and Consolidation Well Beyond 6-Month Reporting

Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer

Visualizing Data for Hypothesis Generation Using Large-Volume Health care Claims Data

Identifying Adult Mental Disorders with Existing Data Sources

Training Sessions 3 and 4: Introduction to SEER, Medicare and SEER-Medicare

Types of Prostate Radiation Data Points # 16

Financial Disclosure. Learning Objectives. Review and Impact of the NCDB PUF. Moderator: Sandra Wong, MD, MS, FACS, FASCO

A Population-Based Study of the Effectiveness of Bisphosphonates at Reducing Hip Fractures among High Risk Women

Surveillance and SEER Where are we going? NAACCR Meeting June 23, 2017 Lynne Penberthy MD, MPH

birthplace and length of time in the US:

PDF MEDICARE PREVENTIVE SERVICES QUICK REFERENCE EBOOK

General Information. Please silence cell phones. Locations Restrooms to the left of the ballroom, or to your right by the elevators

The American Experience

We see health care. differently. Comprehensive data Novel insights Transformative actions Lasting value

2017 Community Oncology Alliance 1

30 TPHA Journal Volume 65, Issue 2

Transcription:

CERCIT Workshop: About the Data: Texas Cancer Registry; Medicaid; Registry Linked Claims Data MelanieWilliams,PhD,Manager, Texas Cancer Registry Melanie Williams, PhD, Manager, Texas Cancer Registry Cheryl Bowcock, MPH, Epidemiologist, Texas Cancer Registry Catherine Cooksley, DrPH, Senior Biostatistician, UTMB

Workshop Objectives Overview of the TCR data Cancer registry linkages Strategies Uses Linkage results of the TCR & Medicare databases Overview of Texas Medicaid Data Methods used (or to be used) in linked data that will be used in CERCIT studies Case Studies Using Linked Cancer Registry & Claims Data Limitations of the linked data Review of how linked data will be used in CERCIT projects 2 4

Methods used (or to be used) in linked data that will be used in CERCIT studies Case Studies using linked Registry Claims Data

Process of linking the SEER (TCR) and Medicare Two steps. Step 1. If an SSN is available. Agreement of both files on SSN plus first and last name or last name, month of birth and sex first name, month of birth and sex Step 2. If an SSN is not available or does not match in Step 1 If no match in Step 1 Agreement between both hfiles on: Last name, first name, month of birth and sex Plus agreement on 7 or 8 digits of the SSN If an SSN is not available Agreement on two or more: Year of birth, dayof birth, middle initial, or date of death

TCR Medicare NCI and their CMS contractor, IMS performed the linkage of TCR Medicare data we will use Used U dsame method used with SEER Medicare TCR MC data organized in a similar manner to SEER Medicare TCR MC data has a few variable differences

TCR Medicare TCR MC data organized in a similar manner to SEER Medicare TCR MC data has a few variable differences TC Registry assigned patient id for cancer cases, and Shuffled HICs for the non cancer cohort. Include zip code and census tract variables of patient Include chemotherapy and hormone therapy variables Include all cancer patients even those that resided outside of TX Hospital provider numbers encrypted. Includes Hospital files with same encrypted number to link to the hospitals in MEDPAR and Outpatient files. fl The hospital files will include the hospital's zip code, but no hospital name or address information other than the zip code Include the zip code for physicians on the claims

Case studies: Example using SEER Medicare Data Risk of colorectal cancer in men on long term androgen deprivation therapy for prostate cancer Silke Gillessen, Arnoud Templeton, Giancarlo Marra, Yong Fang Kuo, Emanuele Valtorta, Vahakn B. Shahinian 1760 1770 JNCI Vol. 102, Issue 23 December 1, 2010

Case studies: Example using TCR Medicare Data (different method)

Purpose: To estimate cervical cancer survival by the riskfactors suspected to affect it, namely demographics, comorbidities and treatment among older women Mthd Methods population based survival analysis data sources: Texas Cancer Registry linked by SSN to Medicare claims files Denominator files Medicare provider analysis file (MEDPAR) Outpatient Inpatient p Vital Statistics 2000 Census age 65+ at cancer diagnosis invasive cervical cancer diagnosed between 1999 and 2001

Case Study Coker et. al. Limitations Restricted Population Older only US resident or documented only (SSN) Cannot study access to care because all have similar access If private insurance used, treatment may be underestimated Conclusions Lack of treatment in MC data consistent with TCR: 31% vs 30% for those 65+ Claim that there were ethnic differences observed, does not appear to be statistically supported Authors claim that may indicate access to care issues

Case Study Coker et. al. TCR Cancer Site Cancer Histology Disease Stage Age at Cancer Dx Date of Dx Latitude at dx * Longitude at dx * Medicare Comorbidities Treatment Timing of Tx

Case Study Coker et. al. How the data we will be using compares linkage was 88% vs 94 97% in the data we will use geographic variable block level vs zip code We will have Carrier claims files for physician office visits Part D Event data (mark the July workshop kh on your calendar)

TCR linked Medicaid data Linked registry Medicaid data can identify indigent patients and the timing of Medicaid coverage with cancer diagnosis. Still working out details 2 step process provide better quality linkage than single deterministic process TCR and TX Medicaid id data both under TX DSHS TCR will do the first step Cancer registry cases to Medicaid by Name, SSN, Gender We could stop there and use TX Medicaid claims files but Chose to use Medicaid Analytic Extract (MAX) files TCR works withcms contractor (whoprepared our unlinkedmax files) Contractor will then create crosswalk from the TCR provided Medicaid ids to the Encrypted ids on ourmax files, Provide us the file of TCR cases with a unique id we can then link to our MAX files

Case study: Cancer Registry Data Compared to Medicaid Data Linking Tumor Registry and Medicaid idclaims to Evaluate Cancer Care Delivery Deborah Schrag, M.D.,., M.P.H., Beth A.Virnig, Ph.D.,.,and Joan L. Warren, Ph.D. Health Care Financing Review/Summer 2009/Volume 30, Number 4

Case Study Schragg (cont.) Objective: Evaluate how well Medicaid claims capture diagnostic and treatment information recorded by the California Cancer Registry (CCR). To estimate the potential numbers of patients specific to cancer site that could be identified from a Medicaid registry Linkage timing of enrollment in relationship to date of cancer diagnosis Data Sources California Cancer Registry (CCR) California Medicaid Pre existing CCR Medicaid Linkage

The actual linkage success of capturing cancer pts in Medicaid varied by tumor site (5% prostate 34% Hepatoma) 9% Breast and 20% for CRC When Comparing claims Medicaid claims agreed with CCR for diagnoses: 73% of Breast Cancer cases 68 % Colon Cancer cases For Surgery 67% Breast Limitations

Limitations Old data One state No access to plan specific requirements for submission of itemized claims

Review of studies we will do PROJECTS Project 1 studies utilization of screening tests for breast, colorectal and prostate cancer, examining the predictors for and outcomes of underutilization, appropriate utilization, and overutilization of these tests. t Project 2 studies receipt and quality of cancer treatment in Texas; whether specific patients, cancer types, and areas of the state are at risk for substandard therapy; and the impact of the availability of specific cancer specialists on cancer therapy. Project 3 assesses post treatment surveillance testing, both underuse and overuse, with respect to guidelines, for those with breast, colon, lung and pancreatic cancer. It measures how patient, provider and system characteristics affect such care. Project 4 measures supportive care in Texas cancer patients, compared to national guidelines. It assesses the use and outcomes of supportive processes such as emesis prevention, infection prevention, bone health, cardiac health and end of life care.

Variables will use

THANK YOU!